US Bare Metal Stent Devices Market - Size, Share, Segmentation, Regional Insights, Key Players & Forecast, 2026–2035

By 2035, the US Bare Metal Stent Devices Market is projected to reach approximately USD 1.38 billion, growing at a CAGR of 2.9% during the forecast period 2026–2035. The market was valued at USD 1.05 billion in 2025, with historical analysis covering 2021 to 2024.

While drug eluting stents dominate the broader stent landscape, bare metal stents (BMS) continue to retain clinical relevance in specific patient populations and procedural scenarios. In the United States, BMS are often preferred in patients with high bleeding risk, those unable to tolerate prolonged dual antiplatelet therapy (DAPT), and in cost-sensitive hospital settings.

The US interventional cardiology ecosystem, characterized by high PCI volumes and advanced catheterization infrastructure, continues to sustain stable demand for BMS. Although the market is relatively mature, it remains structurally important within cardiovascular device procurement portfolios.

Bare metal stents are particularly utilized in acute myocardial infarction settings where rapid endothelialization is desired. Additionally, in peripheral vascular interventions, certain anatomical and reimbursement scenarios favor BMS deployment.

Introduction

According to the US Bare Metal Stent Devices Market Report, this segment of the cardiovascular device industry remains strategically significant despite the widespread adoption of drug eluting stents. Bare metal stents are metallic scaffold devices implanted into narrowed arteries to restore blood flow without incorporating drug-eluting polymer coatings.

In the United States, coronary artery disease remains the leading cause of mortality, contributing to nearly 700,000 deaths annually. Percutaneous coronary intervention procedures exceed one million annually, and while DES account for the majority of implants, BMS continue to be used in select clinical indications.

BMS offer advantages such as faster endothelial healing, reduced requirement for prolonged DAPT, and lower device costs compared to DES. These factors make them clinically relevant in patients undergoing non-cardiac surgery soon after PCI or those with elevated bleeding risks.

Regulatory oversight by the US Food and Drug Administration (FDA) ensures quality and safety compliance. The established reimbursement framework under Medicare and private insurers further supports stable procedural volumes involving BMS.

Key Market Drivers: What’s Sustaining the US Bare Metal Stent Devices Market?

• High Prevalence of Acute Coronary Syndromes
  The persistent burden of acute coronary syndromes across the US sustains baseline demand for BMS. In emergency PCI settings, certain cardiologists prefer BMS due to shorter recommended DAPT durations, particularly in patients with compliance concerns.
• Cost Sensitivity and Hospital Procurement Strategies
  Bare metal stents are priced lower than drug eluting alternatives. In hospital systems operating under bundled payment models, procurement teams often maintain BMS inventory for cost optimization strategies.
• Shorter Dual Antiplatelet Therapy Requirements
  For patients requiring non-cardiac surgery within months of PCI, BMS implantation may be clinically advantageous due to shorter DAPT requirements. This remains a meaningful niche driver in US interventional cardiology.

Innovation in Focus: Evolution of Bare Metal Stent Platforms

While innovation in BMS is slower compared to DES, manufacturers continue refining metallic platforms to improve flexibility, radial strength, and deliverability. Ultra-thin strut designs and cobalt chromium materials have enhanced procedural success rates.

Imaging-guided PCI using IVUS and OCT has improved stent optimization even in BMS procedures, reducing restenosis risks. Peripheral BMS innovation has also focused on improved durability in femoropopliteal arteries.

Recent Developments

Recent years have seen stabilization rather than aggressive expansion in BMS innovation. Manufacturers focus on maintaining regulatory compliance, improving material strength, and ensuring competitive pricing strategies.

Procurement consolidation within US hospital systems has influenced vendor negotiations. Additionally, increasing preference for outpatient vascular interventions may support selective peripheral BMS growth.

Conclusion

The US Bare Metal Stent Devices Market Size & Share reflects a mature but clinically relevant segment within the broader cardiovascular device industry. While growth remains modest compared to DES markets, BMS retain importance in specific patient populations and cost-sensitive environments.

Stable PCI volumes, defined clinical niches, and established reimbursement structures support sustained market presence through 2035. Regional demographic trends, particularly aging populations in the South and West, will continue influencing state-level demand patterns.

The market’s future will be characterized by incremental technological refinement, pricing competitiveness, and strategic positioning within broader interventional cardiology portfolios.

The US Bare Metal Stent Devices Competitive Landscape is moderately consolidated. Key players include:

• Abbott Laboratories – Maintains legacy BMS platforms supporting specific US clinical needs.
• Boston Scientific Corporation – Offers metallic stent solutions integrated with broad cardiovascular portfolios.
• Medtronic plc – Provides coronary and peripheral stent solutions within US hospital networks.
• Terumo Corporation – Expanding US vascular intervention footprint.
• Biotronik SE & Co. KG – Known for precision-engineered coronary stents in select US markets.
• B. Braun Melsungen AG – Participates in vascular intervention device distribution.
• Cook Medical – Strong presence in peripheral vascular devices.
• MicroPort Scientific Corporation – Growing US distribution partnerships.
• Meril Life Sciences – Emerging competitor in US cardiovascular device space.
• OrbusNeich Medical – Focused on niche coronary applications.
• Elixir Medical – Developing advanced metallic stent technologies.
• Cardinal Health – Major distributor supporting hospital procurement.
• Teleflex Incorporated – Provides complementary interventional devices.
• Stryker Corporation – Engaged in peripheral vascular segments.
• Philips Healthcare – Supplies cath lab imaging systems.
• Siemens Healthineers – Supports interventional imaging infrastructure.
• GE HealthCare – Major imaging and cath lab solutions provider.
• Lepu Medical Technology – Expanding global footprint.
• Reva Medical – Investigated bioresorbable scaffolds.
• Amaranth Medical – Focused on vascular scaffold innovation.

• Coronary Bare Metal Stents (Dominant Segment)
  Coronary BMS account for the majority of revenue in this market. These stents are primarily used in acute myocardial infarction cases and specific elective PCI scenarios.
  High-volume cardiac centers across states such as California, Texas, and New York maintain BMS inventory to address patient-specific contraindications to DES.
• Peripheral Bare Metal Stents
  Peripheral BMS are utilized in lower extremity arterial disease, especially in femoral and iliac arteries. Peripheral interventions in aging diabetic populations continue to support this segment.

• Stainless Steel (Traditional Segment)
  Stainless steel remains historically significant in BMS manufacturing due to strength and cost-effectiveness.
• Cobalt Chromium (Dominant Modern Segment)
  Cobalt chromium BMS offer thinner struts and improved flexibility, making them more deliverable in complex lesions.
• Platinum Chromium
  Platinum chromium enhances radiopacity, aiding accurate deployment under fluoroscopy.
• Others
  Emerging metal alloys with improved biocompatibility are under evaluation in niche applications.

• Hospitals (Largest Segment)
  Major tertiary care hospitals perform the majority of PCI procedures in the US. High emergency admission volumes support consistent BMS usage.
• Cardiac Catheterization Laboratories
  Standalone cath labs and heart institutes contribute significantly, particularly in metropolitan regions.
• Ambulatory Surgical Centers
  While limited in coronary interventions, ASCs are gradually expanding into peripheral procedures involving BMS.

• Coronary Artery Disease
  This remains the primary application segment, supported by stable CAD prevalence across the US.
• Peripheral Artery Disease
  Rising PAD incidence among diabetic and elderly populations sustains peripheral BMS demand.
• Others
  Includes renal artery stenosis and select vascular indications.

West Region

The West region leads in advanced interventional cardiology adoption. California accounts for the largest state-level share due to its large population and dense network of cardiac centers. Los Angeles and San Francisco host high-volume cath labs performing thousands of PCIs annually.

Washington and Colorado exhibit strong tertiary care infrastructure. Arizona and Oregon show growing peripheral intervention volumes, particularly in elderly populations.

States such as Nevada, Utah, and Hawaii contribute modestly but demonstrate stable PCI rates aligned with population size.

Northeast Region

The Northeast benefits from academic medical centers in New York, Massachusetts, and Pennsylvania. High patient inflow and advanced cardiology departments support steady BMS usage in complex cases.

Connecticut and New Jersey show strong insurance coverage penetration, supporting procedural accessibility. Smaller states like Rhode Island and Vermont contribute proportionally smaller shares.

South Region

The South region is witnessing steady growth due to high cardiovascular disease prevalence. Texas and Florida account for significant procedural volumes due to population size and aging demographics.

Georgia and North Carolina demonstrate expanding hospital infrastructure. Alabama and South Carolina exhibit elevated CAD prevalence rates, supporting BMS usage.

States including Mississippi and Louisiana show high comorbidity burdens, influencing interventional cardiology demand.

Midwest Region

The Midwest region demonstrates stable growth. Illinois and Ohio represent key markets with established cardiac centers in Chicago and Cleveland.

Michigan and Minnesota benefit from integrated healthcare systems emphasizing evidence-based PCI practices. Rural states such as Nebraska and South Dakota show lower absolute volumes but stable utilization rates.

1. US Bare Metal Stent Devices Market: Market Introduction & Context

1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecasting Models
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (Manufacturers, Suppliers, Distributors, Hospitals, Cath Labs)

What this section provides: Introduces the study scope, research framework, definitions, assumptions, and reliability standards used to analyze the US Bare Metal Stent Devices Market.

2. US Bare Metal Stent Devices Market: Executive Summary

2.1 Key Insights & Market Snapshot
2.2 Analyst Viewpoint
2.3 Market Attractiveness Index

What this section provides: Offers a concise yet strategic overview of market size, growth trajectory, investment attractiveness, and competitive positioning.

3. US Bare Metal Stent Devices Market: Market Dynamics & Outlook

3.1 Drivers and their Impact Analysis
3.2 Restraints and their Impact Analysis
3.3 Opportunities and their Impact Analysis
3.3.1 Emerging Clinical Niches
3.3.2 Cost-Driven Procurement Trends
3.4 Patent & Innovation Analysis (2020–2025)

What this section provides: Explains the macro and micro factors shaping demand, innovation shifts, and competitive opportunities in the US BMS landscape.

4. US Bare Metal Stent Devices Market: Market Environment & Industry

4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis by Region (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Impact of Digitalization
4.6 Application & Innovation Landscape
4.7 Regulatory Framework Analysis (FDA & CMS)
4.8 Import/Export Restrictions & Tariff Impact
4.9 Government Initiatives
4.10 Impact of Escalating Geopolitical Tensions

What this section provides: Delivers a complete industry environment overview, regulatory context, pricing evolution, and structural competitive forces.

5. US Bare Metal Stent Devices Market – By Product Type

5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.3 Coronary Bare Metal Stents
5.4 Peripheral Bare Metal Stents

What this section provides: Highlights demand distribution across coronary and peripheral BMS platforms and identifies revenue-driving categories.

6. US Bare Metal Stent Devices Market – By Material

6.1 Overview
6.2 Segment Share Analysis, By Material, 2025 & 2035 (%)
6.3 Stainless Steel
6.4 Cobalt Chromium
6.5 Platinum Chromium
6.6 Others

What this section provides: Analyzes material-based innovation, cost differentiation, and physician preference trends.

7. US Bare Metal Stent Devices Market – By Application

7.1 Overview
7.2 Segment Share Analysis, By Application, 2025 & 2035 (%)
7.3 Coronary Artery Disease
7.4 Peripheral Artery Disease
7.5 Others

What this section provides: Identifies major clinical applications and growth hotspots across cardiovascular indications.

8. US Bare Metal Stent Devices Market – By End-User

8.1 Overview
8.2 Segment Share Analysis, By End-User, 2025 & 2035 (%)
8.3 Hospitals
8.4 Cardiac Catheterization Laboratories
8.5 Ambulatory Surgical Centers

What this section provides: Breaks down demand concentration by healthcare delivery settings across the United States.

9. US Bare Metal Stent Devices Market – By Geography

9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)

9.3 West Region

9.3.1 Regional Overview & Trends
9.3.2 West Region Bare Metal Stent Devices Key Manufacturers
9.3.3 West Region Market Size and Forecast, By State, 2025–2035 (US$ Million)
9.3.4 West Region Market Size and Forecast, By Product Type
9.3.5 West Region Market Size and Forecast, By Material
9.3.6 West Region Market Size and Forecast, By Application
9.3.7 West Region Market Size and Forecast, By End-User

9.3.8 California
9.3.8.1 Overview
9.3.8.2 California Market Size and Forecast, By Product Type
9.3.8.3 California Market Size and Forecast, By Material
9.3.8.4 California Market Size and Forecast, By Application
9.3.8.5 California Market Size and Forecast, By End-User

9.3.9 Washington
9.3.10 Colorado
9.3.11 Arizona
9.3.12 Oregon

9.3.13 Others
9.3.13.1 Utah
9.3.13.2 Nevada
9.3.13.3 New Mexico
9.3.13.4 Idaho
9.3.13.5 Montana
9.3.13.6 Wyoming
9.3.13.7 Alaska
9.3.13.8 Hawaii

What this section provides: Delivers deep state-level insights into PCI volumes, hospital density, cardiovascular disease prevalence, and procurement trends in the Western US.

9.4 Northeast Region

9.4.1 Regional Overview & Trends
9.4.2 New York
9.4.3 Massachusetts
9.4.4 New Jersey
9.4.5 Pennsylvania
9.4.6 Connecticut

9.4.7 Others
9.4.7.1 Maine
9.4.7.2 Vermont
9.4.7.3 New Hampshire
9.4.7.4 Rhode Island
9.4.7.5 Delaware

What this section provides: Examines high-density cardiac centers and academic hospitals driving BMS utilization in the Northeast.

9.5 South Region

9.5.1 Regional Overview & Trends
9.5.2 Texas
9.5.3 Florida
9.5.4 Georgia
9.5.5 North Carolina
9.5.6 Tennessee
9.5.7 South Carolina
9.5.8 Alabama

9.5.9 Others
9.5.9.1 Mississippi
9.5.9.2 Louisiana
9.5.9.3 Arkansas
9.5.9.4 Kentucky
9.5.9.5 Oklahoma
9.5.9.6 Maryland
9.5.9.7 Virginia
9.5.9.8 West Virginia

What this section provides: Highlights the impact of high CAD prevalence and aging demographics on BMS demand in the Southern US.

9.6 Midwest Region

9.6.1 Regional Overview & Trends
9.6.2 Illinois
9.6.3 Ohio
9.6.4 Michigan
9.6.5 Minnesota
9.6.6 Indiana
9.6.7 Wisconsin
9.6.8 Missouri

9.6.9 Others
9.6.9.1 Iowa
9.6.9.2 Kansas
9.6.9.3 Nebraska
9.6.9.4 North Dakota
9.6.9.5 South Dakota

What this section provides: Analyzes procedural volumes and healthcare infrastructure distribution across Midwestern states.

10. US Bare Metal Stent Devices Market: Competitive Landscape & Company Profiles

10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix (Leaders, Innovators, Emerging Players)

10.3 Company Profiles

10.3.1 Abbott Laboratories
10.3.2 Boston Scientific Corporation
10.3.3 Medtronic plc
10.3.4 Terumo Corporation
10.3.5 Biotronik SE & Co. KG
10.3.6 B. Braun Melsungen AG
10.3.7 Cook Medical
10.3.8 MicroPort Scientific Corporation
10.3.9 Meril Life Sciences Pvt. Ltd.
10.3.10 OrbusNeich Medical
10.3.11 Elixir Medical
10.3.12 Cardinal Health
10.3.13 Teleflex Incorporated
10.3.14 Stryker Corporation
10.3.15 Philips Healthcare
10.3.16 Siemens Healthineers
10.3.17 GE HealthCare
10.3.18 Lepu Medical Technology
10.3.19 Reva Medical
10.3.20 Amaranth Medical

What this section provides: Benchmarks key players, market shares, and strategic initiatives shaping the US Bare Metal Stent Devices competitive landscape.

11. US Bare Metal Stent Devices Market: Future Market Outlook (2025–2035)

11.1 Scenario Analysis (Optimistic, Realistic, Pessimistic)
11.2 Disruptive Technologies Impact
11.3 Emerging Business Trends
11.4 Business Opportunities for Startups and Existing Players

What this section provides: Presents forward-looking projections, technology evolution, and long-term growth strategies.

12. US Bare Metal Stent Devices Market: Strategic Recommendations

What this section provides: Offers actionable recommendations for manufacturers, investors, healthcare providers, and distributors.

13. US Bare Metal Stent Devices Market: Disclaimer

What this section provides: Clarifies legal boundaries, data limitations, and report usage conditions.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Bare Metal Stent Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Bare Metal Stent Devices Market: Material Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Material
TABLE 9: US Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 10: US Bare Metal Stent Devices Market: Application Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by Application
TABLE 12: US Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 13: US Bare Metal Stent Devices Market: End-User Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by End-User
TABLE 15: US Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 16: US Bare Metal Stent Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Bare Metal Stent Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 21: California Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 22: California Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 23: Washington Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 25: Washington Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 26: Washington Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 27: Colorado Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 29: Colorado Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 30: Colorado Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 31: Arizona Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 33: Arizona Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 34: Arizona Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 35: Oregon Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 37: Oregon Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 38: Oregon Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 39: West – Others Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 41: West – Others Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 42: West – Others Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 45: New York Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 46: New York Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 47: Massachusetts Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 49: Massachusetts Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 50: Massachusetts Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 51: New Jersey Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 53: New Jersey Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 54: New Jersey Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 59: Connecticut Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 61: Connecticut Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 62: Connecticut Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 69: Texas Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 70: Texas Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 71: Florida Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 73: Florida Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 74: Florida Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 75: Georgia Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 77: Georgia Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 78: Georgia Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 79: North Carolina Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 81: North Carolina Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 82: North Carolina Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 83: Tennessee Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 85: Tennessee Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 86: Tennessee Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 87: South Carolina Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 89: South Carolina Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 90: South Carolina Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 91: Alabama Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 93: Alabama Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 94: Alabama Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 95: South – Others Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 97: South – Others Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 98: South – Others Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 101: Illinois Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 102: Illinois Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 103: Ohio Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 105: Ohio Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 106: Ohio Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 107: Michigan Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 109: Michigan Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 110: Michigan Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 111: Minnesota Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 113: Minnesota Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 114: Minnesota Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 115: Indiana Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 117: Indiana Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 118: Indiana Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 119: Wisconsin Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 121: Wisconsin Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 122: Wisconsin Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 123: Missouri Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 125: Missouri Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 126: Missouri Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Bare Metal Stent Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Bare Metal Stent Devices Market, by Material, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Bare Metal Stent Devices Market, by Application, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Bare Metal Stent Devices Market, by End-User, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)

List of Figures

FIGURE 1: US Bare Metal Stent Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTLE Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 12: Material Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Material Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 14: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 15: Application Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 16: End-User Segment Market Share Analysis, 2025 & 2035
FIGURE 17: End-User Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 20: West Region US Bare Metal Stent Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Bare Metal Stent Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Bare Metal Stent Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Bare Metal Stent Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 26: Washington Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 27: Colorado Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 28: Arizona Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 29: Oregon Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 30: Others (West Region) Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 33: Florida Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 34: Georgia Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 35: North Carolina Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 36: Tennessee Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 37: South Carolina Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 38: Alabama Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 39: Others (South Region) Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 42: Ohio Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 43: Michigan Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 44: Minnesota Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 45: Indiana Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 46: Wisconsin Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 47: Missouri Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 51: Massachusetts Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 52: New Jersey Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 53: Pennsylvania Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 54: Connecticut Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Bare Metal Stent Devices Market Size, Forecast and Trend Analysis, 2025–2035 (USD Million)